Vycor Medical Inc
VYCO· OTC
Released Aug 16, 2021
10-Q filed Aug 16, 2021, 47 days after period end · 0001493152-21-020079
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2021 | Q2 2020 | Q2 2019 | Q2 2018 |
|---|---|---|---|---|
| Revenue | $491.43K | $244.27K | $411.90K | $301.67K |
| Net Income | -$9.37K | -$248.89K | -$185.30K | -$418.58K |
| EPS Diluted | $0.00 |
Vycor Medical Inc · CIK 1424768 · Engraved from SEC EDGAR
| -$0.01 |
| -$0.01 |
| -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.